These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 10847761)

  • 1. Bioluminescent fusion conjugates and bioluminescent immunoassays: 1988-1998.
    Kricka LJ; Stroebel J; Stanley PE
    Luminescence; 1999; 14(1):39-46. PubMed ID: 10847761
    [No Abstract]   [Full Text] [Related]  

  • 2. Bibliography. Luminescence literature. Bioluminescent fusion proteins.
    Luminescence; 2003; 18(5):300-2. PubMed ID: 14655670
    [No Abstract]   [Full Text] [Related]  

  • 3. Bibliography. Luminescence literature. Chemiluminescent and bioluminescent immunoassays.
    Kricka LJ
    Luminescence; 2002; 17(5):343-53. PubMed ID: 12407673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioluminescent fusion conjugates and bioluminescent immunoassays: 1988-1998.
    Kricka LJ; Stroebel J; Stanley PE
    Luminescence; 1999 Jan; 14(1):39-46. PubMed ID: 10398559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bibliography. Luminescence literature. Chemiluminescent and bioluminescent immunoassays.
    Luminescence; 2003; 18(5):283-300. PubMed ID: 14587081
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioluminescent signal system: bioluminescence immunoassay of pathogenic organisms.
    Frank L; Markova S; Remmel N; Vysotski E; Gitelson I
    Luminescence; 2007; 22(3):215-20. PubMed ID: 17286244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luciferase-YFP fusion tag with enhanced emission for single-cell luminescence imaging.
    Hoshino H; Nakajima Y; Ohmiya Y
    Nat Methods; 2007 Aug; 4(8):637-9. PubMed ID: 17618293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A bioluminescent molecular switch for glucose.
    Teasley Hamorsky K; Ensor CM; Wei Y; Daunert S
    Angew Chem Int Ed Engl; 2008; 47(20):3718-21. PubMed ID: 18383457
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioluminescence resonance energy transfer (BRET) for the real-time detection of protein-protein interactions.
    Pfleger KD; Seeber RM; Eidne KA
    Nat Protoc; 2006; 1(1):337-45. PubMed ID: 17406254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using epitope-aequorin conjugate recognition in immunoassays for complex proteins.
    Desai UA; Wininger JA; Lewis JC; Ramanathan S; Daunert S
    Anal Biochem; 2001 Jul; 294(2):132-40. PubMed ID: 11444808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of a homogeneous noncompetitive immunoassay based on bioluminescence resonance energy transfer.
    Arai R; Nakagawa H; Tsumoto K; Mahoney W; Kumagai I; Ueda H; Nagamune T
    Anal Biochem; 2001 Feb; 289(1):77-81. PubMed ID: 11161297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression immunoassay.
    White SR; Chiu NH; Christopoulos TK
    Methods; 2000 Sep; 22(1):24-32. PubMed ID: 11020314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly sensitive and rapid tandem bioluminescent immunoassay using aequorin labeled Fab fragment and biotinylated firefly luciferase.
    Ito K; Nishimura W; Maeda M; Gomi K; Inouye S; Arakawa H
    Anal Chim Acta; 2007 Apr; 588(2):245-51. PubMed ID: 17386817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A homogeneous bioluminescent inhibition immunoassay to detect anti-interferon gamma antibodies.
    Bradhurst P; Stoyanov A; Nithichanon A; Bundell C; Urriola N
    Clin Exp Immunol; 2024 Nov; 218(3):283-290. PubMed ID: 38975719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barnase-barstar high affinity interaction phenomenon as the base for the heterogenous bioluminescence pseudorabies virus' immunoassay.
    Rudenko NV; Sinegina LL; Arzhanov MA; Ksenzenko VN; Ivashina TV; Morenkov OS; Shaloiko LA; Vinokurov LM
    J Biochem Biophys Methods; 2007 Jun; 70(4):605-11. PubMed ID: 17355894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemiluminescent and bioluminescent assays as innovative prospects for mycotoxin determination in food and feed.
    Sarter S; Zakhia N
    Luminescence; 2004; 19(6):345-51. PubMed ID: 15558672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of ultra-high sensitivity bioluminescent enzyme immunoassay for prostate-specific antigen (PSA) using firefly luciferase.
    Seto Y; Iba T; Abe K
    Luminescence; 2001; 16(4):285-90. PubMed ID: 11512145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Alkylated 6'-aminoluciferins are bioluminescent substrates for Ultra-Glo and QuantiLum luciferase: new potential scaffolds for bioluminescent assays.
    Woodroofe CC; Shultz JW; Wood MG; Osterman J; Cali JJ; Daily WJ; Meisenheimer PL; Klaubert DH
    Biochemistry; 2008 Sep; 47(39):10383-93. PubMed ID: 18771284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of luminescence immunoassays.
    Barnard GJ; Collins WP
    Med Lab Sci; 1987 Jul; 44(3):249-66. PubMed ID: 3323761
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoassay with cytomegalovirus early antigens from gene products p52 and CM2 (UL44 and UL57) detects active infection in patients with chronic fatigue syndrome.
    Beqaj SH; Lerner AM; Fitzgerald JT
    J Clin Pathol; 2008 May; 61(5):623-6. PubMed ID: 18037660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.